INFLARX NV (IFRX:NASDAQ)
$2.05 -0.01 (-0.4854%)
Analysed INFLARX NV (IFRX:NASDAQ) News Sources
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
04-05-2026
yahoo.com
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
06-05-2026
yahoo.com
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
06-05-2026
yahoo.com
InflaRx N.V. (IFRX) Regains Compliance With Nasdaq
07-05-2026
yahoo.com
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
08-05-2026
yahoo.com
InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and Renal Disease Pipeline
08-05-2026
marketbeat.com
Here’s Why InflaRx (IFRX) is Among the 10 Most Volatile Penny Stocks to Buy Now
31-05-2026
yahoo.com
What Do Analysts Say About InflaRx N.V. (IFRX)?
10-06-2026
yahoo.com
Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength?
26-06-2026
yahoo.com
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
30-06-2026
yahoo.com
What is the current price of INFLARX NV (IFRX:NASDAQ)?
The current price of INFLARX NV (IFRX:NASDAQ) is $2.05.
INFLARX NV (IFRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of INFLARX NV (IFRX:NASDAQ) since the previous trading day is $-0.01.
INFLARX NV (IFRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of INFLARX NV (IFRX:NASDAQ) since the previous trading day is -0.4854%.
What is the most recent average sentiment score for INFLARX NV (IFRX:NASDAQ)?
The most recent average sentiment score for INFLARX NV (IFRX:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for INFLARX NV (IFRX:NASDAQ)?
The most recent sentiment for INFLARX NV (IFRX:NASDAQ) is .
SEC-8K** Filing Available For INFLARX NV (IFRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.